Zobrazeno 1 - 10
of 10
pro vyhledávání: '"BJ Srinivasa"'
Autor:
Antonio Passaro, Filippo de Marinis, Hai-Yan Tu, Konstantin K. Laktionov, Jifeng Feng, Artem Poltoratskiy, Jun Zhao, Eng Huat Tan, Maya Gottfried, Victor Lee, Dariusz Kowalski, Cheng Ta Yang, BJ Srinivasa, Laura Clementi, Tejaswini Jalikop, Dennis Chin Lun Huang, Agnieszka Cseh, Keunchil Park, Yi-Long Wu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundAfatinib is approved for first-line treatment of patients with epidermal growth factor receptor mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC). Here, we report findings from a combined analysis of three phase IIIb studies of
Externí odkaz:
https://doaj.org/article/9f20422dd14b455088226a15dd90831a
Autor:
BJ Srinivasa, Bhanu Prakash Lalkota, Girish Badarke, Diganta Hazarika, Nasiruddin Mohammad, Sulav Sapkota, Mansi Khanderia, D Tousif, Raghavendra Rao, Amritanshu Ram, Shekar Patil, Radheshyam Naik
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 12 (2018)
Background: Eribulin mesylate is a non-taxane microtubule inhibitor which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of er
Externí odkaz:
https://doaj.org/article/17d9df9007f0458e8761743c698fc60d
Autor:
BJ Srinivasa, PS Sridhar, BhanuPrakash Lalkota, Nomsa Tsikai, PS Niyati, Mansi Shah, S Anuradha, R Roopesh, Veena Ramaswamy, Radheshyam Naik, BS Ajaikumar
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:495
Autor:
ArunKumar Dahiya, SenthilJ Rajappa, BJ Srinivasa, ShaileshA Bondarde, ParthaMohan Gokhale, Pankaj Sonone
Publikováno v:
Oncology Journal of India. 5:116
Autor:
Ghosh, Mithua, Balaram, Gautam, ML, Sheela, CR, Krishna, Patil, Shekar, PS, Sridhar, Thungappa, Satheesh Chiradoni, Bhattacharjee, Somarat, Kodandapani, Ramya, K, Vijay, E, Vijay, Ghorpade, Suhas N., Dasgupta, Roshini, Naseer, Mohammed, Katragadda, Shanmukh, Ravichandran, Aarthi, Ramaswamy, Veena, Bj, Srinivasa, Rao, Vishal Uchila Shishir, Ajaikumar, Basavalinga Sadasivaiah
Publikováno v:
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15166-e15166, 1p
Autor:
Lalkota BP; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India., Srinivasa BJ; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Swamy MV; Center for Academics and Research, HCG Foundation, Bangalore, India., Hazarika D; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India., Jeet BM; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India., Jyothi K; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India., Ghosh M; Department of Molecular Pathology, HCG Cancer Speciality Center, Bangalore, India., Sayeed SM; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India., Nasiruddin M; Department of Molecular Pathology, HCG Cancer Speciality Center, Bangalore, India., Naik R; Department of Translational Medicine and Therapeutics, HCG Cancer Speciality Center, Bangalore, India.
Publikováno v:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan-Mar; Vol. 19 (2), pp. 208-213.
Autor:
Srinivasa BJ; Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India., Sridhar PS; Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India., Lalkota BP; Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India., Tsikai N; Department of Clinical Oncology, Harare Oncology Centre, Harare, Zimbabwe., Niyati PS; Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India., Shah M; Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India., Anuradha S; Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India., Roopesh R; Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India., Ramaswamy V; Department of Histopathology, HCG-SC, Bengaluru, Karnataka, India., Naik R; Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India., Ajaikumar BS; Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India.
Publikováno v:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Dec; Vol. 18 (Supplement), pp. S495-S497.
Autor:
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, 510080, China., Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China., Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China., Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Chang J; Fudan University Shanghai Cancer Center, Shanghai, 200032, China., Wang J; Fudan University Shanghai Cancer Center, Shanghai, 200032, China., Cheng Y; Division of Thoracic Oncology, Jilin Province Cancer Hospital, Changchun, 130012, China., Zhu J; Division of Thoracic Oncology, Jilin Province Cancer Hospital, Changchun, 130012, China., Tan EH; Department of Medical Oncology, National Cancer Centre, Singapore, 169610, Singapore., Li K; Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China., Zhang Y; Zhejiang Cancer Hospital, Hangzhou, 310022, China., Lee V; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China., Yang CT; Department of Thoracic Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, 333, Taiwan., Su WC; National Cheng Kung University Hospital, Tainan, 704, Taiwan., Lam DC; Departments of Clinical Oncology, and Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Srinivasa BJ; HCG Hospital, Bangalore, 560020, India., Rajappa S; Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, 500034, India., Ho CL; Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan., Lam KC; Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China., Hu Y; Department of Oncology, Chinese PLA General Hospital, Beijing, 100853, China., Bondarde SA; Shatabdi Superspeciality Hospital, Nashik, 422005, India., Liu X; 307th Hospital of PLA, Beijing, 100070, China., Tian Y; Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China., Xue Z; Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China., Cseh A; Boehringer Ingelheim International GmbH, 55216, Ingelheim, Germany., Huang DC; Boehringer Ingelheim Taiwan Limited, Taipei, 104, Taiwan., Zhou C; Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200433, China., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. syylwu@live.cn.
Publikováno v:
Targeted oncology [Target Oncol] 2022 Jan; Vol. 17 (1), pp. 1-13. Date of Electronic Publication: 2022 Jan 12.
Autor:
Passaro A; Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., de Marinis F; Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China., Laktionov KK; Russian Academy of Medical Sciences, Moscow, Russia., Feng J; Jiangsu Provincial Tumor Hospital, Nanjing, China., Poltoratskiy A; Petrov Research Institute of Oncology, St Petersburg, Russia., Zhao J; Peking University Cancer Hospital & Institute, Beijing, China., Tan EH; National Cancer Centre, Singapore, Singapore., Gottfried M; Tel Aviv University, Tel Aviv, Israel., Lee V; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Kowalski D; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Yang CT; Chang Gung Memorial Hospital, Guishan, Taoyuan, Taiwan., Srinivasa BJ; HCG Hospital, Bangalore, India., Clementi L; Boehringer Ingelheim Italia S.p.A., Milan, Italy., Jalikop T; Syneos Health, Raleigh, NC, United States., Huang DCL; Boehringer Ingelheim Taiwan Limited, Taipei, Taiwan., Cseh A; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Park K; Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jul 09; Vol. 11, pp. 709877. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021).
Autor:
Srinivasa BJ; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Lalkota BP; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Badarke G; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Hazarika D; Department of Histopathology, Molecular Pathology & Cytogenetics, Triesta Sciences R&D (A Unit of HCG Cancer Speciality Center), Bangalore, India., Mohammad N; Department of Histopathology, Molecular Pathology & Cytogenetics, Triesta Sciences R&D (A Unit of HCG Cancer Speciality Center), Bangalore, India., Sapkota S; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Khanderia M; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Tousif D; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Rao R; Center for Academics and Research, HCG Foundation, Bangalore, India., Ram A; Center for Academics and Research, HCG Foundation, Bangalore, India., Patil S; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India., Naik R; Department of Medical Oncology, HCG Cancer Speciality Center, Bangalore, India.
Publikováno v:
Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2018 Jun 28; Vol. 12, pp. 1179554918782475. Date of Electronic Publication: 2018 Jun 28 (Print Publication: 2018).